首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

1392054

胸膜疾病市場：依疾病類型、診斷工具、治療手段、最終使用者、地區

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

出版日期: 2023年11月02日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年，全球胸膜疾病市場規模為50.1億美元，預計2023年至2030年複合年成長率為7.2%，到2030年將達到81.3億美元。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	50.1億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	7.20%	2030年市場規模預測	81.3億美元

圖 1. 2023 年依地區分類的胸膜疾病全球市場佔有率(%)

胸膜疾病包括影響胸膜（肺部周圍的薄膜）的多種疾病。這些疾病會對呼吸功能和整體健康產生重大影響。胸膜透過提供潤滑並允許呼吸過程中的平穩運動，在維持肺部結構和功能完整性方面發揮重要作用。胸膜疾病可由多種原因引起，包括感染疾病、發炎、腫瘤和接觸有害物質。常見的胸膜疾病包括胸膜炎、胸腔積水、氣胸和間皮瘤。識別症狀、準確診斷症狀並實施適當的治療策略對於管理患者和改善全球受這些具有挑戰性的胸膜疾病影響的患者的治療結果至關重要。在吸菸、結核和轉移等相關風險因子盛行率上升的推動下，全球胸膜疾病市場多年來一直穩定成長。此外，診斷影像技術和雷射治療等診斷和治療方法的重大技術進步正在進一步支持市場成長。

市場動態：

預計協定等無機策略的日益普及也將推動預測期內的市場增長。例如，2020 年 11 月，製藥公司 Taiho Pharmaceutical Co.， Ltd. 和臨床階段生物製藥公司 Lung Therapeutics， Inc. 宣佈在日本達成重組人單鏈尿激酶纖溶酶原啟動劑 LTI-01 局部胸腔積液的獨家許可協定，該藥物目前正在由 Lung Tx 開發。

然而，認知度低、診斷延遲、診斷工具和治療成本、專業知識和資源缺乏預計將阻礙預測期內全球胸膜疾病市場的成長。

本研究的主要特點

該報告詳細分析了全球胸膜疾病市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
本報告還揭示各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
本報告還提供有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
本報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球胸膜疾病市場的主要企業。
該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
全球胸膜疾病市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球胸膜疾病市場的各種策略矩陣，將促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 5.01 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.20%	2030 Value Projection:	US$ 8.13 Bn

Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung's structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging global pleural diseases. The global global pleural diseases market has been steadily growing over the years driven by the rising prevalence of associated risk factors such as smoking, tuberculosis, and metastases. Furthermore, the market has witnessed significant technological advancements in diagnosis and treatment modalities such as imaging techniques and laser therapy, further supporting the market growth.

Market Dynamics:

The increasing adoption of inorganic strategies such as agreement is also expected to drive the growth of the market over the forecast period. For instance, in November 2020, Taiho Pharmaceutical Co., Ltd, a pharmaceutical company, and Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions, for the territory of Japan.

However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the global pleural diseases market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the global pleural diseases market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Pleural Diseases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pleural diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural diseases market

Global Pleural Diseases Market Segmentation Detailed Segmentation:

By Disease Types:
- Pleurisy
- Pleural Effusion
- Pneumothelioma
- Mesothelioma
- Others
By Diagnostic Tools:
- Imaging Techniques
- Molecular Diagnostics
- Thoracoscopy and Pleuroscopy
By Treatment Modalities:
- Medications
- Thoracentesis and Pleurodesis
- Minimally Invasive Interventions
- Surgical Interventions
By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Research and Academic Institutions
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Bristol Myers Squibb
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Sanofi
- AbbVie Inc.
- Braun SE
- Becton, Dickinson and Company
- Bicakcilar
- Biometrix
- Cook Medical
- Grena
- Redax
- Rocket Medical
- Smith Medical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Pleural Diseases, By Disease Type
- Market Pleural Diseases, By Diagnostic Tools
- Market Pleural Diseases, By Treatment Modalities
- Market Pleural Diseases, By End User
- Market Pleural Diseases, By Geography/Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Respiratory diseases
- Restraints
Limited Availability of Expertise and Resources
- Opportunities
Emerging Biomarkers and Precision Medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pleural Diseases Market, By Disease Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pleurisy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Pleural Effusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Pneumothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Mesothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Imaging Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 20218-2030, (US$ Billion)
Thoracoscopy and Pleuroscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Pleural Diseases Market, By Treatment Modalities, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Thoracentesis and Pleurodesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Minimally Invasive Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Surgical Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Pleural Diseases Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Research and Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Global Pleural Diseases Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)

10. Competitive Landscape

Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bicakcilar
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biometrix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cook Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Grena
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Redax
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Rocket Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Smith Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

胸膜疾病市場：依疾病類型、診斷工具、治療手段、最終使用者、地區

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市場動態：

目錄

第1章研究目的與假設

第2章市場展望

第3章市場動態、法規及趨勢分析

第4章全球胸膜疾病市場 -冠狀病毒(COVID-19) 大流行的影響

第5章全球胸膜疾病市場，依疾病類型，2018-2030

第6章全球胸膜疾病市場（依診斷工具），2018-2030 年

第7章全球胸膜疾病市場，依治療方式，2018-2030

第 8 章全球胸膜疾病市場，依最終用戶分類，2018-2030 年

第9章全球胸膜疾病市場，依地區，2018-2030

第10章競爭形勢

第11章章節

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2018-2030, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2018-2030, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2018-2030, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2018-2030, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2018-2030, (US$ Bn)

10. Competitive Landscape

11. Section

胸膜疾病市場：依疾病類型、診斷工具、治療手段、最終使用者、地區

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市場動態：

目錄

第1章 研究目的與假設

第2章 市場展望

第3章市場動態、法規及趨勢分析

第4章全球胸膜疾病市場 -冠狀病毒(COVID-19) 大流行的影響

第5章全球胸膜疾病市場，依疾病類型，2018-2030

第6章 全球胸膜疾病市場（依診斷工具），2018-2030 年

第7章全球胸膜疾病市場，依治療方式，2018-2030

第 8 章全球胸膜疾病市場，依最終用戶分類，2018-2030 年

第9章全球胸膜疾病市場，依地區，2018-2030

第10章競爭形勢

第11章 章節

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2018-2030, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2018-2030, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2018-2030, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2018-2030, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2018-2030, (US$ Bn)

10. Competitive Landscape

11. Section

第1章研究目的與假設

第2章市場展望

第6章全球胸膜疾病市場（依診斷工具），2018-2030 年

第11章章節